Salvage treatment for patients with refractory or relapsed aggressive non-Hodgkinxxxs lymphoma with dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab: Preliminary results of a multicenter phase it trial.

U Mey; D Flieger; Josef Birkmann; A Ho; D Huhn; U Kaiser; Y Ko; A Kraemer; A Neubauer; Martin Wilhelm; C Hahn; G Haarmann; A Glasmacher; I Schmidt-Wolf

Salvage treatment for patients with refractory or relapsed aggressive non-Hodgkinxxxs lymphoma with dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab: Preliminary results of a multicenter phase it trial.

U Mey, D Flieger, Josef Birkmann, A Ho, D Huhn, U Kaiser, Y Ko, A Kraemer, A Neubauer, Martin Wilhelm, C Hahn, G Haarmann, A Glasmacher, I Schmidt-Wolf

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	309B-309B
Journal	BLOOD
Volume	100
Issue number	11
Publication status	Published - 2002
Event	44th Annual Meeting of the American-Society-of-Hematology - PHILADELPHIA, PENNSYLVANIA Duration: 6 Dec 2002 → 10 Dec 2002

Cite this

Mey, U., Flieger, D., Birkmann, J., Ho, A., Huhn, D., Kaiser, U., Ko, Y., Kraemer, A., Neubauer, A., Wilhelm, M., Hahn, C., Haarmann, G., Glasmacher, A., & Schmidt-Wolf, I. (2002). Salvage treatment for patients with refractory or relapsed aggressive non-Hodgkinxxxs lymphoma with dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab: Preliminary results of a multicenter phase it trial. BLOOD , 100(11), 309B-309B.

Mey, U ; Flieger, D ; Birkmann, Josef et al. / Salvage treatment for patients with refractory or relapsed aggressive non-Hodgkinxxxs lymphoma with dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab: Preliminary results of a multicenter phase it trial. In: BLOOD 2002 ; Vol. 100, No. 11. pp. 309B-309B.

@article{6e7c38708a5849cea2aa82b64019f758,

title = "Salvage treatment for patients with refractory or relapsed aggressive non-Hodgkinxxxs lymphoma with dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab: Preliminary results of a multicenter phase it trial.",

author = "U Mey and D Flieger and Josef Birkmann and A Ho and D Huhn and U Kaiser and Y Ko and A Kraemer and A Neubauer and Martin Wilhelm and C Hahn and G Haarmann and A Glasmacher and I Schmidt-Wolf",

year = "2002",

language = "English",

volume = "100",

pages = "309B--309B",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "11",

note = "44th Annual Meeting of the American-Society-of-Hematology ; Conference date: 06-12-2002 Through 10-12-2002",

}

Mey, U, Flieger, D, Birkmann, J, Ho, A, Huhn, D, Kaiser, U, Ko, Y, Kraemer, A, Neubauer, A, Wilhelm, M, Hahn, C, Haarmann, G, Glasmacher, A & Schmidt-Wolf, I 2002, 'Salvage treatment for patients with refractory or relapsed aggressive non-Hodgkinxxxs lymphoma with dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab: Preliminary results of a multicenter phase it trial.', BLOOD , vol. 100, no. 11, pp. 309B-309B.

Salvage treatment for patients with refractory or relapsed aggressive non-Hodgkinxxxs lymphoma with dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab: Preliminary results of a multicenter phase it trial. / Mey, U; Flieger, D; Birkmann, Josef et al.
In: BLOOD , Vol. 100, No. 11, 2002, p. 309B-309B.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Salvage treatment for patients with refractory or relapsed aggressive non-Hodgkinxxxs lymphoma with dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab: Preliminary results of a multicenter phase it trial.

AU - Mey, U

AU - Flieger, D

AU - Birkmann, Josef

AU - Ho, A

AU - Huhn, D

AU - Kaiser, U

AU - Ko, Y

AU - Kraemer, A

AU - Neubauer, A

AU - Wilhelm, Martin

AU - Hahn, C

AU - Haarmann, G

AU - Glasmacher, A

AU - Schmidt-Wolf, I

PY - 2002

Y1 - 2002

M3 - Abstract (Journal)

SN - 0006-4971

VL - 100

SP - 309B-309B

JO - BLOOD

JF - BLOOD

IS - 11

T2 - 44th Annual Meeting of the American-Society-of-Hematology

Y2 - 6 December 2002 through 10 December 2002

ER -

Mey U, Flieger D, Birkmann J, Ho A, Huhn D, Kaiser U et al. Salvage treatment for patients with refractory or relapsed aggressive non-Hodgkinxxxs lymphoma with dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab: Preliminary results of a multicenter phase it trial. BLOOD . 2002;100(11):309B-309B.